Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-25 @ 7:07 PM
Study NCT ID:
NCT04768504
Status:
TERMINATED
Last Update Posted:
2024-11-25
First Post:
2021-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study
Sponsor:
Khashayar Esfahani
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-20
First Submit QC Date:
None
Study First Post Date:
2021-02-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-20
Last Update Post Date:
2024-11-25
Last Update Post Date Type:
ACTUAL